Validating the meta-analytical results on MDM2, CASP8, XRCC3 polymorphisms and breast cancer risk: Examination of Hardy-Weinberg Equilibrium

Breast Cancer Research and Treatment

Volumn 126, Issue 3, 2011, Pages 819-823

  Sergentanis, Theodoros N ^a,b   Economopoulos, Konstantinos P ^a,b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Society of Junior Doctors   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; PROTEIN MDM2; XRCC3 PROTEIN;

BREAST CANCER; CANCER RISK; CASP8 GENE; GENE FREQUENCY; HARDY WEINBERG DISTRIBUTION LAW; HUMAN; LETTER; MDM2 GENE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VALIDITY; XRCC3 GENE;

EID: 79958704549     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1291-3     Document Type: Letter

References (14)

1. Mao C, Liao RY, Chen Q (2010) Sensitivity analyses including and excluding the HWE-violating studies are required for meta-analyses of genetic association studies. Breast Cancer Res Treat 121:245-246
2. Sergentanis TN, Economopoulos KP (2010) GSTT1 and GSTP1 polymorphisms and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 121:195-202
3. Economopoulos KP, Sergentanis TN (2010) Differential effects of MDM2 SNP309 polymorphism on breast cancer risk along with race: a meta-analysis. Breast Cancer Res Treat 120:211-216
4. Sergentanis TN, Economopoulos KP (2010) Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis. Breast Cancer Res Treat 120:229-234
5. Economopoulos KP, Sergentanis TN (2010) XRCC3 Thr241Met polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 121:439-443
6. Thakkinstian A, McElduff P, D'Este C, Duffy D, Attia J (2005) A method for meta-analysis of molecular association studies. Stat Med 24:1291-1306 (Pubitemid 40585169)
7. Rohlfs RV, Weir BS (2008) Distributions of Hardy-Weinberg equilibrium test statistics. Genetics 180:1609-1616
8. Yu KD, Rao NY, Chen AX, Fan L, Yang C, Shao ZM (2010) A systematic review of the relationship between polymorphic sites in the estrogen receptor-beta (ESR2) gene and breast cancer risk. Breast Cancer Res Treat (in press)
9. Schmidt MK, Reincke S, Broeks A, Braaf LM, Hogervorst FB, Tollenaar RA, Johnson N, Fletcher O, Peto J, Tommiska J et al (2007) Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium. Cancer Res 67:9584-9590 (Pubitemid 47535950)
10. Haiman CA, Garcia RR, Kolonel LN, Henderson BE, Wu AH, Le Marchand L (2008) A promoter polymorphism in the CASP8 gene is not associated with cancer risk. Nat Genet 40:259-260 author reply 260-251 (Pubitemid 351311777)
11. Costa S, Pinto D, Pereira D, Rodrigues H, Cameselle-Teijeiro J, Medeiros R, Schmitt F (2007) DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population. Breast Cancer Res Treat 103:209-217 (Pubitemid 46789140)
12. Dufloth RM, Costa S, Schmitt F, Zeferino LC (2005) DNA repair gene polymorphisms and susceptibility to familial breast cancer in a group of patients from Campinas, Brazil. Genet Mol Res 4:771-782
13. Krupa R, Synowiec E, Pawlowska E, Morawiec Z, Sobczuk A, Zadrozny M, Wozniak K, Blasiak J (2009) Polymorphism of the homologous recombination repair genes RAD51 and XRCC3 in breast cancer. Exp Mol Pathol 87:32-35
14. Breast Cancer Association Consortium (2006) Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. J Natl Cancer Inst 98:1382-1396